• Home
  • Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease.

Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease.

Author List
Stenmark MH, Blas K, Halverson S, Sandler HM, Feng FY, Hamstra DA
Publication
International journal of radiation oncology, biology, physics
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1484028
Publication Year
2011
PubMed ID
21645976
Publication Title
Stenmark MH, Blas K, Halverson S, Sandler HM, Feng FY, Hamstra DA. Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e335-44.